Keensight Capital-backed CatSci to acquire Reach Separations.

Keensight Capital-backed CatSci, a company specializing in CMC development and pharmaceutical innovation, agreed to acquire Reach Separations, a company focused on advanced chromatography and purification services. Financial terms were not disclosed. “We are excited to welcome Reach Separations into the CatSci Group. The need for solving complex analytical problems while meeting the ever-evolving regulatory demands is growing fast. Joining forces with Reach gives our customers access to end-to-end coverage of the analytical development lifecycle, taking them from discovery through to manufacture, and ultimately enabling them to help patients in need," Ross Burn, CatSci CEO.